Burrill & Company Announces Second Close of Burrill Capital Fund IV, L.P.

(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 08/02/12 -- Burrill & Company today announced a second close of its Burrill Capital Fund IV, L.P., bringing the aggregate capital commitments to $505 million.

The fund will invest globally in the life sciences, including early- to late-stage investments in therapeutics, diagnostics, medical devices, healthcare delivery, wellness, and digital health.

"We are pleased that our new fund generated strong interest among investors," says G. Steven Burrill, CEO of Burrill & Company, a global life sciences financial services firm. "This is a time of great opportunities globally for investors in the life sciences, not just in traditional sectors, but emerging areas brought about by the convergence of healthcare and information technology."

About Burrill & Company
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With $1.5 billion in assets under management, the firm's businesses include venture capital/private equity, merchant banking, and media. By leveraging the scientific and business networks of its team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. This unique combination of resources and capabilities enables the company to provide life sciences companies with capital, transactional support, management expertise, insight, market intelligence, and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe, and Asia. For more information visit: .





Contact:
Daniel Levine
Managing Director
Burrill & Company

415-591-5449

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 02.08.2012 - 12:45 Uhr
Sprache: Deutsch
News-ID 171163
Anzahl Zeichen: 0

contact information:
Town:

SAN FRANCISCO, CA

Kategorie:

Healthcare

Diese Pressemitteilung wurde bisher 195 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Burrill & Company Announces Second Close of Burrill Capital Fund IV, L.P."
steht unter der journalistisch-redaktionellen Verantwortung von

Burrill & Company (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Life Sciences Companies Finish First Half of 2013 With Torrid Pace of Financings ...

SAN FRANCISCO, CA -- (Marketwired) -- 07/01/13 -- Life Sciences companies raised $56.2 billion in cash during the first half of 2013 -- 60.4 percent more than the $35 billion raised during the same period a year ago -- as companies capitalized on ri ...

Life Sciences IPOs Have Biggest Month in 13 Years, Burrill & Company Says ...

SAN FRANCISCO, CA -- (Marketwired) -- 06/04/13 -- A total of eight life sciences companies went public on U.S. exchanges in May, the busiest month for initial public offerings in the sector since August 2000 when 16 issues debuted, Burrill & Com ...

Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies B ...

SAN FRANCISCO, CA -- (Marketwired) -- 05/01/13 -- Global M&A activity in the life sciences sector continues to lag the pace of 2012, but signs point to activity increasing as the largest pharmaceutical companies continue to sit on large amounts ...

Alle Meldungen von Burrill & Company